- Home
- LTRY vs LGVN Comparison
LTRY vs LGVN Comparison
Compare LTRY & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- LGVN
- Stock Information
- Founded
- LTRY 2015
- LGVN 2014
- Country
- LTRY United States
- LGVN United States
- Employees
- LTRY N/A
- LGVN N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- LTRY Technology
- LGVN Health Care
- Exchange
- LTRY Nasdaq
- LGVN Nasdaq
- Market Cap
- LTRY N/A
- LGVN 30.0M
- IPO Year
- LTRY N/A
- LGVN 2021
- Fundamental
- Price
- LTRY $0.49
- LGVN $2.05
- Analyst Decision
- LTRY
- LGVN Strong Buy
- Analyst Count
- LTRY 0
- LGVN 2
- Target Price
- LTRY N/A
- LGVN $8.00
- AVG Volume (30 Days)
- LTRY 52.0K
- LGVN 393.9K
- Earning Date
- LTRY 11-29-2024
- LGVN 11-08-2024
- Dividend Yield
- LTRY N/A
- LGVN N/A
- EPS Growth
- LTRY N/A
- LGVN N/A
- EPS
- LTRY N/A
- LGVN N/A
- Revenue
- LTRY $5,723,382.00
- LGVN $1,229,000.00
- Revenue This Year
- LTRY N/A
- LGVN $161.78
- Revenue Next Year
- LTRY N/A
- LGVN $8.62
- P/E Ratio
- LTRY N/A
- LGVN N/A
- Revenue Growth
- LTRY 125.44
- LGVN 39.34
- 52 Week Low
- LTRY $0.50
- LGVN $0.77
- 52 Week High
- LTRY $7.01
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- LTRY 34.24
- LGVN 52.20
- Support Level
- LTRY $0.51
- LGVN $1.76
- Resistance Level
- LTRY $0.57
- LGVN $2.26
- Average True Range (ATR)
- LTRY 0.03
- LGVN 0.12
- MACD
- LTRY 0.01
- LGVN 0.05
- Stochastic Oscillator
- LTRY 0.00
- LGVN 58.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.